Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dara L Aisner

Showing results (11-20 of 130) with videos related to

Pageof 13
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2014
Is there clinical value to prognostic signatures in early-stage NSCLC?Paul A Bunn, Fred R Hirsch, Dara L Aisner
Current Opinion in Genetics & Development|January 16, 2002
Telomerase regulation: not just flipping the switchDara L Aisner, Woodring E Wright, Jerry W Shay
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 16, 2013
Erlotinib response in an NSCLC patient with a novel compound G719D+L861R mutation in EGFREamon M Berge, Dara L Aisner, Robert C Doebele
Surgical Pathology Clinics|February 4, 2016
Molecular Pathology of Non-Small Cell Lung CancerHilary S Serracino, Wilbur A Franklin, Dara L Aisner
Clinical Chemistry|February 23, 2026
All for One and One for All? The Role of RNA-Based Next-Generation Sequencing in the Molecular Profiling of TumorsAmy Guimaraes-Young, Kurtis D Davies, Dara L Aisner
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 28, 2019
Ready or Not, Here I Come: Inflammatory Myofibroblastic Tumors With Kinase Alterations Revealed Through Molecular Hide and SeekKurtis D Davies, Victor M Villalobos, Dara L Aisner
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Precision Medicine in Non-Small Cell Lung Cancer: Current Standards in Pathology and Biomarker InterpretationNoah A Brown, Dara L Aisner, Geoffrey R Oxnard
Frontiers in Oncology|January 24, 2022
Case Report: Significant Clinical Benefit From Pemetrexed-Based Therapy in ROS1- and ALK-rearranged Lung Cancer With Adenosquamous HistologyTejas Patil, Yunan Nie, Dara L Aisner, et al.
The American Journal of Surgical Pathology|January 13, 2015
BRAF VE1 immunoreactivity patterns in epithelioid glioblastomas positive for BRAF V600E mutationBette K Kleinschmidt-DeMasters, Dara L Aisner, Nicholas K Foreman
The Journal of Molecular Diagnostics : JMD|May 11, 2019
Detection of Tumor NTRK Gene Fusions to Identify Patients Who May Benefit from Tyrosine Kinase (TRK) Inhibitor TherapySusan J Hsiao, Ahmet Zehir, Anthony N Sireci, et al.
Pageof 13

Showing results (11-20 of 130) with videos related to

Sort By:
Pageof 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2014
Is there clinical value to prognostic signatures in early-stage NSCLC?Paul A Bunn, Fred R Hirsch, Dara L Aisner
Current Opinion in Genetics & Development|January 16, 2002
Telomerase regulation: not just flipping the switchDara L Aisner, Woodring E Wright, Jerry W Shay
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 16, 2013
Erlotinib response in an NSCLC patient with a novel compound G719D+L861R mutation in EGFREamon M Berge, Dara L Aisner, Robert C Doebele
Surgical Pathology Clinics|February 4, 2016
Molecular Pathology of Non-Small Cell Lung CancerHilary S Serracino, Wilbur A Franklin, Dara L Aisner
Clinical Chemistry|February 23, 2026
All for One and One for All? The Role of RNA-Based Next-Generation Sequencing in the Molecular Profiling of TumorsAmy Guimaraes-Young, Kurtis D Davies, Dara L Aisner
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 28, 2019
Ready or Not, Here I Come: Inflammatory Myofibroblastic Tumors With Kinase Alterations Revealed Through Molecular Hide and SeekKurtis D Davies, Victor M Villalobos, Dara L Aisner
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Precision Medicine in Non-Small Cell Lung Cancer: Current Standards in Pathology and Biomarker InterpretationNoah A Brown, Dara L Aisner, Geoffrey R Oxnard
Frontiers in Oncology|January 24, 2022
Case Report: Significant Clinical Benefit From Pemetrexed-Based Therapy in ROS1- and ALK-rearranged Lung Cancer With Adenosquamous HistologyTejas Patil, Yunan Nie, Dara L Aisner, et al.
The American Journal of Surgical Pathology|January 13, 2015
BRAF VE1 immunoreactivity patterns in epithelioid glioblastomas positive for BRAF V600E mutationBette K Kleinschmidt-DeMasters, Dara L Aisner, Nicholas K Foreman
The Journal of Molecular Diagnostics : JMD|May 11, 2019
Detection of Tumor NTRK Gene Fusions to Identify Patients Who May Benefit from Tyrosine Kinase (TRK) Inhibitor TherapySusan J Hsiao, Ahmet Zehir, Anthony N Sireci, et al.
Pageof 13